KLK6 and glioblastoma: Kallikrein 6 (KLK6) levels have been shown to be elevated in patients with multiple types of malignancies, including glioblastoma,77 colorectal,78 laryngeal,79 gastric,80 and ovarian cancers,81 as well as prostate cancer.